Company Presentation • 22 Oct 2024 06:00
Investor Update
Company Presentation • 15 Aug 2023 09:00
H2 2023
Company Presentation • 14 Feb 2023 18:05
H1 2023
Company Presentation • 17 Aug 2022 17:49
H2 2022
Company Presentation • 14 Dec 2021 18:38
𝛼SK or SearchENTITY
CSL (CSL AT)
CSL (CSL AT)
2
Analysis
Health Care • United States
CSL Limited develops, manufactures, and markets human pharmaceutical and diagnostic products derived from human plasma. The Company provides products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
morex